I’m not at all concerned about the Squalamine IND. What I am somewhat concerned about is the IL-9 program (#msg-2700495).
MEDI reports 1Q04 financial results tomorrow, and there’s a possibility (hopefully, a remote one) that MEDI could announce they are suspending the IL-9 program indefinitely or pulling out altogether.
If you must worry about something, worry about IL-9. I think the Squalamine AMD program is in good shape.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.